Stellantis
The Business Development & Strategy role at Stellantis focuses on leading global business development efforts with a primary emphasis on North America. The position involves launching innovative partnerships, influencing product development, and driving revenue growth for the company's new Software Group. This role requires collaborating with cross-functional teams to identify market trends and execute strategic initiatives that enhance the customer experience.
Stellantis is a leading global automaker and mobility group formed in 2021 through the merger of Fiat Chrysler Automobiles (FCA) and Groupe PSA. It brings together a broad portfolio of passenger-vehicle and light‑commercial brands (including Jeep, Ram, Fiat, Peugeot, Citroën, Opel/Vauxhall, Alfa Romeo, Maserati and others) across mass‑market and premium segments. The company operates a global manufacturing and R&D footprint and is investing heavily in electrification, software-defined vehicles, connectivity and sustainable mobility solutions. Stellantis positions itself to deliver customer-focused products and services while advancing decarbonization and new mobility business models worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Stellantis.
Stellantis didn’t post a salary, so this is our estimate from similar listings.
Stellantis appoints Charles Christman as Head of Investor Relations
4 days ago
Head of Business Development & Strategy
Jubilee Media
Business Development Lead, Audio Partnerships
The Trade Desk
AI Data Center Business Development Manager
SK hynix
Product Business Development Manager - Kaye
Amphenol
Senior Business Development Manager (USA Remote)
Turnitin, LLC
Business Development Manager - Licensing
Biocytogen